@Miss_Pinterest Como ya he dicho, hay que seguir estudiándolo, pero no me lo estoy inventando: https://t.co/lJmPicaUhf https://t.co/Ma0qHyZwx8 https://t.co/LlpST3F2In
RT @Cochrane_GNOCG: On the 8th day of advent …. https://t.co/CjmFW0haoK Bringing you a run down of our 2017 reviews & protocols in our Coc…
RT @Cochrane_GNOCG: On the 8th day of advent …. https://t.co/CjmFW0haoK Bringing you a run down of our 2017 reviews & protocols in our Coc…
On the 8th day of advent …. https://t.co/CjmFW0haoK Bringing you a run down of our 2017 reviews & protocols in our Cochrane GNOC evidence advent calendar…… #CGNOCadventcal17 @CochraneLibrary @CochraneUK @cochrancollab https://t.co/1JLc1UzuSe
RT @CastlDalmunzie: #womenhealth #patientcare🙍🏻who need Tx w #clomiphenecitrate should be aware👉🏿 ⏫ #endometrialcancer https://t.co/GTTNJNs…
#womenhealth #patientcare🙍🏻who need Tx w #clomiphenecitrate should be aware👉🏿 ⏫ #endometrialcancer https://t.co/GTTNJNsnch @CochraneLibrary https://t.co/14EVJq3lVt
Women needing treatment with clomiphene citrate could have increased risk of endometrial cancer https://t.co/CjmFW0haoK @cochranecollab
Cochrane: Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility https://t.co/jFDA1NYt9g
Risk of endometrial cancer in women treated with ovary.... https://t.co/10AxdNGaax
Low quality data suggests Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility https://t.co/jn2mRGZWKB https://t.co/PSbb5Hn1CC